General Information of DTT (ID: TTKJEMQ)

DTT Name Glutamate receptor ionotropic NMDA 2A (NMDAR2A) DTT Info
Gene Name GRIN2A

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Discontinued Drug(s)
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Glycine DMIOZ29 Allergic rhinitis CA08.0 Approved [1]
------------------------------------------------------------------------------------
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
NBQX DMPHZI5 Neurological disorder 6B60 Phase 1 [2]
------------------------------------------------------------------------------------
11 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
YM-90K DMWRT4L Convulsion 8A68.Z Discontinued in Phase 2 [3]
DIZOCILPINE DMMGYXR Cerebrovascular ischaemia 8B1Z Terminated [4]
L-687414 DM56VPY N. A. N. A. Terminated [5]
L-689560 DMCVY4U Neurodegenerative disorder 8A20-8A23 Terminated [6]
L-695902 DMT1DNS N. A. N. A. Terminated [5]
L-698532 DMO9HM7 Neurological disorder 6B60 Terminated [7]
L-698544 DMLRBN1 Alzheimer disease 8A20 Terminated [5]
L-701324 DMAIJSX Cerebrovascular ischaemia 8B1Z Terminated [7]
MDL-105519 DMHUJCI N. A. N. A. Terminated [8]
RPR-104632 DM9L50N N. A. N. A. Terminated [9]
SPERMINE DMD4BFY N. A. N. A. Terminated [10]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Discontinued Drug(s)
76 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
(+)-HA966 DMKWEAJ Discovery agent N.A. Investigative [6]
(D)-Ala-Pro-Glu DMGXTSB Discovery agent N.A. Investigative [11]
(R)-2-Amino-5-phosphono-pentanoic acid DMSY4CK Discovery agent N.A. Investigative [12]
(R)-2-Amino-7-phosphono-heptanoic acid DM4XEHR Discovery agent N.A. Investigative [12]
(RS)-(tetrazol-5-yl)glycine DMYZCRF Discovery agent N.A. Investigative [6]
1,3-ditolylguanidine DM04KS1 Discovery agent N.A. Investigative [13]
2-Methylamino-succinic acid(NMDA) DMKP6BM Discovery agent N.A. Investigative [6]
3-Benzoyl-7-chloro-4-hydroxy-1H-quinolin-2-one DMAH4DG Discovery agent N.A. Investigative [5]
3-Hydroxy-1H-benzo[b]azepine-2,5-dione DMZSOPU Discovery agent N.A. Investigative [14]
3-Hydroxy-6-methyl-1H-benzo[b]azepine-2,5-dione DMYR350 Discovery agent N.A. Investigative [14]
3-Hydroxy-7-nitro-1H-benzo[b]azepine-2,5-dione DMTEJOY Discovery agent N.A. Investigative [14]
3-Hydroxy-8-methyl-1H-benzo[b]azepine-2,5-dione DM7HKIF Discovery agent N.A. Investigative [14]
3-phenyl-4-hydroxyquinolin-2(1H)-one DM2C9X8 Discovery agent N.A. Investigative [7]
4,5,7-Trichloro-3-hydroxy-1H-quinolin-2-one DMXZ9PI Discovery agent N.A. Investigative [15]
4,6-Dichloro-1H-indole-2-carboxylic acid DM62XC3 Discovery agent N.A. Investigative [16]
4-Bromo-3-hydroxy-1H-quinolin-2-one DMYOCFX Discovery agent N.A. Investigative [15]
4-Bromo-5,7-dichloro-3-hydroxy-1H-quinolin-2-one DM2QJ5A Discovery agent N.A. Investigative [15]
4-Chloro-3-hydroxy-1H-quinolin-2-one DMMALY3 Discovery agent N.A. Investigative [15]
4-hydroxy-5-phenylthieno[2,3-b]pyridin-6(7H)-one DMT3H2X Discovery agent N.A. Investigative [7]
4-[2-(4-Phenyl-butylamino)-ethyl]-phenol DMXLVJW Discovery agent N.A. Investigative [17]
4-[2-(5-Phenyl-pentylamino)-ethyl]-phenol DM5J7O8 Discovery agent N.A. Investigative [17]
4-[2-(6-Phenyl-hexylamino)-ethyl]-phenol DMLCIJX Discovery agent N.A. Investigative [17]
4-[3-(4-Phenyl-butylamino)-propyl]-phenol DMOF9YN Discovery agent N.A. Investigative [17]
4-[3-(5-Phenyl-pentylamino)-propyl]-phenol DMKDBHN Discovery agent N.A. Investigative [17]
5,7-Dichloro-3-hydroxy-1H-quinazoline-2,4-dione DMUADN4 Discovery agent N.A. Investigative [18]
5,7-Dichloro-4-hydroxy-3-phenyl-1H-quinolin-2-one DMZJKIU Discovery agent N.A. Investigative [5]
5,7-Dinitro-1,4-dihydro-quinoxaline-2,3-dione DMG4UCX Discovery agent N.A. Investigative [5]
6,7-Dichloro-3-hydroxy-1H-quinazoline-2,4-dione DMNEJ8W Discovery agent N.A. Investigative [18]
6-Chloro-1,4-dihydro-quinoxaline-2,3-dione DMURJ34 Discovery agent N.A. Investigative [19]
6-Nitro-1,4-dihydro-quinoxaline-2,3-dione DM84CTA Discovery agent N.A. Investigative [19]
7-chloro-3-hydroxyquinazoline-2,4-dione DM3OMLU Discovery agent N.A. Investigative [20]
8-Bromo-3-hydroxy-1H-benzo[b]azepine-2,5-dione DMPVU7H Discovery agent N.A. Investigative [14]
8-Chloro-3-hydroxy-1H-benzo[b]azepine-2,5-dione DM842L6 Discovery agent N.A. Investigative [14]
8-Ethyl-3-hydroxy-1H-benzo[b]azepine-2,5-dione DMY8W0K Discovery agent N.A. Investigative [14]
8-Fluoro-3-hydroxy-1H-benzo[b]azepine-2,5-dione DMBZSAO Discovery agent N.A. Investigative [14]
Ala-Pro-Glu DMTWB54 Discovery agent N.A. Investigative [11]
AP-7 DMBU942 Discovery agent N.A. Investigative [21]
Benzyl 4-aminobutyl(3-aminopropyl)carbamate DMOKVAT Discovery agent N.A. Investigative [22]
CGP61594 DM8KFZH Discovery agent N.A. Investigative [6]
Conantokin-R DMN4KJI Discovery agent N.A. Investigative [23]
d-AP5 DMY5OTN Discovery agent N.A. Investigative [6]
D-aspartic acid DM7Z892 Discovery agent N.A. Investigative [6]
d-CCPene DM36D0F Discovery agent N.A. Investigative [6]
DNQX DMQXPA5 Discovery agent N.A. Investigative [24]
Gly-Amp-Glu DMO8LAC Discovery agent N.A. Investigative [11]
Gly-b7Pro-Glu DM8L09J Discovery agent N.A. Investigative [11]
Gly-Hyp-Glu DM8XR4Y Discovery agent N.A. Investigative [11]
Gly-Pip-Glu DMM0JA4 Discovery agent N.A. Investigative [11]
H-Gly-D-dmP-Glu-OH DMX2TGD Discovery agent N.A. Investigative [25]
H-Gly-dmP-Glu-OH DMOYQPM Discovery agent N.A. Investigative [25]
homoquinolinic acid DMBW5DU Discovery agent N.A. Investigative [6]
L-aspartic acid DMWGPO6 Hypokalemia 5C77 Investigative [6]
LY233053 DMC82DA Discovery agent N.A. Investigative [6]
MDL 100,453 DMLI5VH Discovery agent N.A. Investigative [26]
N,N'-Bis-(4-butoxy-phenyl)-guanidine DMLOP2B Discovery agent N.A. Investigative [13]
N,N'-Bis-(4-butyl-phenyl)-guanidine DMOS2GH Discovery agent N.A. Investigative [13]
N,N'-Bis-(4-ethyl-phenyl)-guanidine DM0CTG7 Discovery agent N.A. Investigative [13]
N,N'-Bis-(4-hexyl-phenyl)-guanidine DM0RQGU Discovery agent N.A. Investigative [13]
N,N'-Bis-(4-isopropyl-phenyl)-guanidine DMM38BC Discovery agent N.A. Investigative [13]
N,N'-Bis-(4-sec-butyl-phenyl)-guanidine DMFDXLB Discovery agent N.A. Investigative [13]
N-(2-methoxybenzyl)cinnamamidine DM06S5Z Discovery agent N.A. Investigative [27]
N1-dansyl-spermine DM76CLF Discovery agent N.A. Investigative [6]
Nle-Pro-Glu DM0FA6B Discovery agent N.A. Investigative [11]
NVP-AAM077 DM9DURZ Discovery agent N.A. Investigative [28]
Phe-Pro-Glu DMJMLKA Discovery agent N.A. Investigative [11]
PHENCYCLIDINE DMQBEYX Discovery agent N.A. Investigative [29]
RPR-118723 DMLDWCB Discovery agent N.A. Investigative [9]
TCN-201 DMMT2GP Discovery agent N.A. Investigative [30]
Tenocyclidine DMRM1QV Discovery agent N.A. Investigative [31]
TRANSTORINE DMP4T87 Discovery agent N.A. Investigative [16]
UBP141 DM6IG5J Discovery agent N.A. Investigative [12]
[3H]CGP39653 DMITR7A Discovery agent N.A. Investigative [6]
[3H]CGS19755 DM7H3JN Discovery agent N.A. Investigative [6]
[3H]CPP DMR5UBF Discovery agent N.A. Investigative [6]
[3H]dizocilpine DMEC2PF Discovery agent N.A. Investigative [6]
[3H]MDL105519 DMPKGHB Discovery agent N.A. Investigative [6]
------------------------------------------------------------------------------------
⏷ Show the Full List of 76 Investigative Drug(s)
Molecule Interaction Atlas

References

1 Glycine transport inhibitors for the treatment of schizophrenia: Symptom and disease modification. Curr Opin Drug Discov Devel. 2009 Jul;12(4):468-78.
2 Synthesis, ionotropic glutamate receptor binding affinity, and structure-activity relationships of a new set of 4,5-dihydro-8-heteroaryl-4-oxo-1,2,... J Med Chem. 2001 Sep 13;44(19):3157-65.
3 4,10-Dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives: highly potent and selective AMPA receptors antagonists with... Bioorg Med Chem Lett. 2000 May 15;10(10):1133-7.
4 Synthesis and evaluation of 6,11-ethanohexahydrobenzo[b]quinolizidines: a new class of noncompetitive N-methyl-D-aspartate antagonists. J Med Chem. 1995 Jun 23;38(13):2483-9.
5 Amino acid bioisosteres: design of 2-quinolone derivatives as glycine-site N-methyl-D-aspartate receptor antagonists, Bioorg. Med. Chem. Lett. 3(2):299-304 (1993).
6 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 456).
7 Synthesis of thieno[2,3-b]pyridinones acting as cytoprotectants and as inhibitors of [3H]glycine binding to the N-methyl-D-aspartate (NMDA) receptor. J Med Chem. 2006 Feb 9;49(3):864-71.
8 CoMFA, synthesis, and pharmacological evaluation of (E)-3-(2-carboxy-2-arylvinyl)-4,6-dichloro-1H-indole-2-carboxylic acids: 3-[2-(3-aminophenyl)-2... J Med Chem. 2005 Feb 24;48(4):995-1018.
9 Indeno[1,2-b]pyrazin-2,3-diones: a new class of antagonists at the glycine site of the NMDA receptor with potent in vivo activity. J Med Chem. 2000 Jun 15;43(12):2371-81.
10 Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents. J Med Chem. 2010 May 13;53(9):3611-7.
11 New Gly-Pro-Glu (GPE) analogues: expedite solid-phase synthesis and biological activity. Bioorg Med Chem Lett. 2006 Mar 1;16(5):1392-6.
12 Synthesis and pharmacology of N1-substituted piperazine-2,3-dicarboxylic acid derivatives acting as NMDA receptor antagonists. J Med Chem. 2005 Apr 7;48(7):2627-37.
13 Synthesis and pharmacological evaluation of N,N'-diarylguanidines as potent sodium channel blockers and anticonvulsant agents. J Med Chem. 1998 Aug 13;41(17):3298-302.
14 Analogs of 3-hydroxy-1H-1-benzazepine-2,5-dione: structure-activity relationship at N-methyl-D-aspartate receptor glycine sites. J Med Chem. 1996 Nov 8;39(23):4643-53.
15 3-Hydroxy-quinolin-2-ones: Inhibitors of [3H]-glycine binding to the site associated with the NMDA receptor, Bioorg. Med. Chem. Lett. 6(5):499-504 (1996).
16 3-(2-carboxyindol-3-yl)propionic acid derivatives: antagonists of the strychnine-insensitive glycine receptor associated with the N-methyl-D-aspart... J Med Chem. 1990 Nov;33(11):2944-6.
17 Structure-activity relationships for a series of bis(phenylalkyl)amines: potent subtype-selective inhibitors of N-methyl-D-aspartate receptors. J Med Chem. 1998 Aug 27;41(18):3499-506.
18 3-hydroxy-quinazoline-2,4-dione as a useful scaffold to obtain selective Gly/NMDA and AMPA receptor antagonists. Bioorg Med Chem Lett. 2004 May 3;14(9):2345-9.
19 5-(N-oxyaza)-7-substituted-1,4-dihydroquinoxaline-2,3-diones: novel, systemically active and broad spectrum antagonists for NMDA/glycine, AMPA, and... J Med Chem. 1997 Oct 24;40(22):3679-86.
20 Structural investigation of the 7-chloro-3-hydroxy-1H-quinazoline-2,4-dione scaffold to obtain AMPA and kainate receptor selective antagonists. Syn... J Med Chem. 2006 Oct 5;49(20):6015-26.
21 Bioisosteric replacement of the alpha-amino carboxylic acid functionality in 2-amino-5-phosphonopentanoic acid yields unique 3,4-diamino-3-cyclobut... J Med Chem. 1992 Dec 11;35(25):4720-6.
22 Polyamines and the NMDA receptor: modifying intrinsic activities with aromatic substituents. Bioorg Med Chem Lett. 2006 Jun 1;16(11):2837-41.
23 Novel conantokins from Conus parius venom are specific antagonists of N-methyl-D-aspartate receptors. J Biol Chem. 2007 Dec 21;282(51):36905-13.
24 Kynurenic acid derivatives. Structure-activity relationships for excitatory amino acid antagonism and identification of potent and selective antago... J Med Chem. 1991 Apr;34(4):1243-52.
25 The neuroprotective activity of GPE tripeptide analogues does not correlate with glutamate receptor binding affinity. Bioorg Med Chem Lett. 2006 Jul 1;16(13):3396-400.
26 Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys. J Pharmacol Exp Ther. 1999 Sep;290(3):1034-40.
27 Indole-2-carboxamidines as novel NR2B selective NMDA receptor antagonists. Bioorg Med Chem Lett. 2005 Dec 15;15(24):5439-41.
28 Relating NMDA receptor function to receptor subunit composition: limitations of the pharmacological approach. J Neurosci. 2006 Feb 1;26(5):1331-3.
29 Synthesis and biological activity of conformationally restricted analogs of milnacipran: (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopro... J Med Chem. 1996 Nov 22;39(24):4844-52.
30 Subunit-selective allosteric inhibition of glycine binding to NMDA receptors. J Neurosci. 2012 May 2;32(18):6197-208.
31 The binding of [3H]thienyl cyclohexylpiperidine ([3H]TCP) to the NMDA-phencyclidine receptor complex. Neuropharmacology. 1989 Jan;28(1):1-7.